GO:0090630 activation of GTPase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090630 (activation of GTPase activity) describes the process that switches an inactive GTPase to its active GTP-bound state by promoting GDP-to-GTP exchange.
• GTPase activation is essential for signal transduction, cytoskeletal dynamics, vesicle trafficking, and nuclear transport.
• Key regulators include guanine nucleotide exchange factors (GEFs) that catalyze nucleotide exchange, while GTPase-activating proteins (GAPs) terminate signaling.
• Dysregulated GTPase activation is implicated in cancer, metabolic disorders, and neurological conditions.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise interrogation of GTPase activation pathways.
• EDITGENE provides end-to-end services for functional validation of GTPase activation, from library screening to bioinformatics.
Description
GTPases are molecular switches that cycle between an inactive GDP-bound state and an active GTP-bound state. The Gene Ontology term GO:0090630, activation of GTPase activity, captures the biological process that initiates this switch by facilitating the replacement of GDP with GTP. This process is fundamental to diverse cellular functions, including signal transduction, cytoskeletal reorganization, membrane trafficking, and nuclear import. Researchers studying cell signaling, cancer biology, and developmental processes rely on understanding how GTPases are activated and how this activation is regulated. The activation of GTPase activity is mediated by guanine nucleotide exchange factors (GEFs), which catalyze the exchange of GDP for GTP, thereby enabling GTPases to interact with downstream effectors. Dysregulation of this process can lead to pathological conditions such as cancer, metabolic disorders, and neurological diseases. Consequently, precise experimental models and methods are needed to dissect the molecular mechanisms and functional consequences of GTPase activation.
activation of GTPase activity At A Glance
| GO ID | GO:0090630 |
|---|---|
| GO term | activation of GTPase activity |
| Ontology | biological_process |
| Synonym | activation of ARF GTPase activity; activation of Cdc42 GTPase activity; activation of Rab GTPase activity; activation of Rac GTPase activity; activation of Ral GTPase activity; activation of Ran GTPase activity; activation of Rap GTPase activity; activation of Ras GTPase activity; activation of Rho GTPase activity; ARF GTPase activation; Cdc42 GTPase activation; Rab GTPase activation; Rac GTPase activation; Ral GTPase activation; Ran GTPase activation; Rap GTPase activation; Ras GTPase activation; Rho GTPase activation |
| Major function | Switching inactive GDP-bound GTPases to active GTP-bound state, enabling downstream signaling. |
| Key regulators | Guanine nucleotide exchange factors (GEFs) promote activation; GTPase-activating proteins (GAPs) promote inactivation. |
| Cellular processes | Signal transduction, cytoskeletal dynamics, vesicle trafficking, nuclear transport. |
| Disease relevance | Cancer, metabolic disorders, neurological diseases. |
What Is GO:0090630?
According to the Gene Ontology, GO:0090630 (activation of GTPase activity) is defined as any process that initiates the activity of an inactive GTPase through the replacement of GDP by GTP. This definition encompasses the activation of various small GTPases, including ARF, Cdc42, Rab, Rac, Ral, Ran, Rap, Ras, and Rho families. The process is typically mediated by guanine nucleotide exchange factors (GEFs) that promote the release of GDP and binding of GTP, thereby switching the GTPase to its active conformation.
Why Is activation of GTPase activity Important in Cell Biology?
The activation of GTPase activity is a central regulatory step in numerous cellular pathways, and its dysregulation is associated with a wide range of human diseases. Understanding how GTPases are activated provides insights into fundamental cell biology and offers potential therapeutic targets. For example, aberrant activation of Rac1 GTPase promotes cancer progression and metastasis, while Ran GTPase activation affects androgen receptor nuclear translocation in prostate cancer. Moreover, exercise-induced adaptations in skeletal muscle depend on Rac1 activation. Thus, studying GO:0090630 is critical for both basic research and translational medicine.
• Controls signal transduction from cell surface receptors to downstream effectors.
• Regulates cytoskeletal reorganization and cell migration.
• Mediates vesicle trafficking and membrane dynamics.
• Facilitates nuclear transport and gene regulation.
• Implicated in cancer initiation, progression, and metastasis.
• Involved in metabolic disorders and exercise adaptation.
• Plays a role in immune cell function and inflammation.
• Target for drug discovery, including covalent inhibitors.
• Essential for developmental processes and tissue homeostasis.
• Provides a model for studying molecular switches and allostery.
What Happens During activation of GTPase activity?
GDP-to-GTP Exchange
In simple terms: The GTPase swaps its 'off' GDP molecule for an 'on' GTP molecule.
The core event in activation of GTPase activity is the replacement of GDP with GTP on the GTPase. This exchange is catalyzed by guanine nucleotide exchange factors (GEFs), which bind to the GTPase and induce conformational changes that reduce its affinity for GDP and increase affinity for GTP. For example, the metabolic enzyme LDHA can act as a noncanonical GEF for Rac1, promoting its activation in cancer cells. Similarly, Rgl2 RalGEF activates Ral GTPase, and its inhibition blocks Ral activation.
Conformational Switch and Effector Binding
In simple terms: Once GTP is bound, the GTPase changes shape to interact with partner proteins.
GTP binding induces conformational changes in the switch I and switch II regions of the GTPase, enabling it to bind downstream effector proteins. This active conformation allows the GTPase to propagate signals to various cellular pathways. For instance, activated Ral GTPase interacts with phospholipase D to mediate v-Src-induced signaling. The intrinsic GTPase activity of K-RAS can be monitored by native mass spectrometry, revealing the dynamics of nucleotide binding.
Regulation by GEFs and GAPs
In simple terms: GEFs turn GTPases on, while GAPs turn them off.
The activation state of a GTPase is tightly controlled by the opposing actions of GEFs and GTPase-activating proteins (GAPs). GEFs promote activation by catalyzing GDP release, whereas GAPs accelerate the intrinsic GTP hydrolysis, returning the GTPase to its inactive state. This balance ensures proper signaling duration and intensity. For example, B-type Plexins promote the GTPase activity of Ran, affecting androgen receptor nuclear translocation in prostate cancer.
Spatiotemporal Control
In simple terms: Activation happens at the right time and place inside the cell.
GTPase activation is spatially and temporally regulated. GEFs are often localized to specific subcellular compartments, ensuring that GTPases are activated only where needed. For example, Rac1 activation occurs at the plasma membrane during cell migration and exercise adaptation. Similarly, Rap1 activation in human neutrophils is rapid and transient, highlighting the dynamic nature of this process.
Key Genes Involved in GO:0090630 activation of GTPase activity
The following genes and proteins are key players in the activation of GTPase activity, serving as GTPases, GEFs, or regulatory factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAC1 | Rho-family GTPase; regulates cytoskeleton and migration | Cancer, exercise adaptation |
| KRAS | Ras-family GTPase; controls proliferation | Cancer, intrinsic GTPase activity |
| RAN | Nuclear transport GTPase | Prostate cancer, nuclear translocation |
| RAP1 | Ras-family GTPase; regulates adhesion and immune function | Neutrophil activation |
| RALA | Ras-family GTPase; vesicle trafficking | Cancer, phospholipase D activation |
| RALB | Ras-family GTPase; exocytosis | Cancer, RalGEF inhibition |
| LDHA | Metabolic enzyme; noncanonical Rac1 GEF | Cancer metabolism |
| RGL2 | RalGEF; activates Ral GTPases | Targeted covalent inhibition |
| PLD1 | Phospholipase D; effector of Ral GTPase | v-Src signaling |
| AR | Androgen receptor; regulated by Ran activation | Prostate cancer |
| CDC42 | Rho-family GTPase; regulates polarity | Cytoskeletal dynamics |
| RHOA | Rho-family GTPase; stress fiber formation | Cell motility |
| ARF1 | ARF-family GTPase; vesicle trafficking | Membrane dynamics |
| RAB5 | Rab-family GTPase; endocytosis | Vesicle transport |
| RAB7 | Rab-family GTPase; late endosome | Trafficking |
| RHEB | Ras-family GTPase; mTORC1 activator | Growth signaling |
| RIT1 | Ras-family GTPase; neuronal differentiation | Cancer, Noonan syndrome |
| RAP2 | Ras-family GTPase; cell adhesion | Immune function |
How Is activation of GTPase activity Regulated?
The activation of GTPase activity is regulated by a complex interplay of guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), and guanine nucleotide dissociation inhibitors (GDIs). GEFs promote activation by facilitating GDP release, while GAPs enhance the intrinsic GTP hydrolysis rate to terminate signaling. Additionally, post-translational modifications such as phosphorylation and lipidation can modulate GEF and GTPase localization and activity. For example, exercise training increases Rac1 activation in skeletal muscle, leading to improved glycogen resynthesis and protein synthesis. Furthermore, metabolic enzymes like LDHA can act as noncanonical GEFs, linking cellular metabolism to GTPase activation.
activation of GTPase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RAC1 | Cancer, exercise adaptation | Knockout, point mutation, overexpression |
| KRAS | Cancer | Point mutation, knock-in |
| RAN | Prostate cancer | Knockout, knock-in |
| RALA/RALB | Cancer | Knockout, overexpression |
| RAP1 | Inflammation | Knockout, overexpression |
Cancer
Dysregulated activation of GTPases is a hallmark of many cancers. Rac1 activation by LDHA promotes cancer cell proliferation and metastasis. Ran GTPase activation by B-type Plexins affects androgen receptor nuclear translocation, contributing to prostate cancer progression. Ral GTPase activation, mediated by RalGEFs such as Rgl2, is implicated in tumorigenesis, and covalent inhibitors targeting RalGEFs are being developed. These findings highlight the therapeutic potential of targeting GTPase activation pathways.
Metabolic Disorders
GTPase activation plays a role in metabolic regulation. Rac1 activation in skeletal muscle is required for exercise-induced adaptations, including glycogen resynthesis and protein synthesis. Dysregulation of this process may contribute to insulin resistance and type 2 diabetes. Additionally, LDHA-mediated Rac1 activation links glycolysis to cancer metabolism, suggesting a broader role in metabolic reprogramming.
Neurological and Inflammatory Diseases
Rap1 activation in human neutrophils is critical for immune responses, and its dysregulation may contribute to inflammatory diseases. Calmodulin inhibits a low Km GTPase activity in rat striatum, suggesting a role in neurological signaling. Furthermore, Ran GTPase activation is essential for nuclear transport, and its impairment has been linked to neurodegenerative disorders.
From activation of GTPase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RAC1 affect exercise adaptation? | Rac1 knockout mouse or cell line |
| Does mutant KRAS alter intrinsic GTPase activity? | KRAS point mutation knock-in |
| Does Ran activation regulate AR nuclear translocation? | RAN knockout or overexpression in prostate cancer cells |
| Can RalGEF inhibition block Ral activation? | RGL2 knockout or covalent inhibitor treatment |
| Does LDHA promote Rac1 activation in cancer? | LDHA knockout or overexpression |
| Does Rap1 activation affect neutrophil function? | Rap1 knockout or overexpression in neutrophils |
How to Study the activation of GTPase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| GTP loading assay | Amount of GTP-bound GTPase | Measure activation state |
| Native mass spectrometry | Intrinsic GTPase activity | Monitor K-RAS nucleotide exchange |
| Pull-down with effector domain | Active GTPase levels | Isolate Rac1-GTP |
| FRET biosensor imaging | Real-time GTPase activation | Live-cell dynamics |
| CRISPR knockout screen | Genes required for activation | Identify GEFs |
| Phosphoproteomics | Downstream signaling changes | Map pathways |
| RNA-seq | Transcriptional responses | Assess gene expression |
| Bioinformatics pathway analysis | Enriched pathways | Interpret screen data |
Biochemical Assays for GTPase Activation
GTPase activation can be measured using biochemical assays such as GTP loading assays, which detect the amount of GTP-bound GTPase. Native mass spectrometry has been used to monitor intrinsic GTPase activity of K-RAS. Additionally, pull-down assays with GST-tagged effector domains (e.g., PAK for Rac1) can isolate active GTPases.
Genetic and CRISPR Screens
CRISPR knockout screens can identify genes required for GTPase activation. For example, a genome-wide screen could reveal GEFs essential for Rac1 activation in cancer cells. Similarly, point mutation knock-in models can dissect the role of specific residues in GTPase function.
Imaging and Live-Cell Dynamics
Fluorescent biosensors (e.g., Raichu-Rac1) enable real-time visualization of GTPase activation in live cells. These sensors have been used to study Rac1 activation during cell migration and exercise adaptation. Similarly, FRET-based sensors can monitor Ran activation in nuclear transport.
Proteomics and Bioinformatics
Mass spectrometry-based proteomics can identify proteins interacting with active GTPases. Bioinformatics analysis of CRISPR screen data can pinpoint pathways enriched in GTPase activation. These approaches are complemented by RNA-seq to assess transcriptional changes upon GTPase activation.
How CRISPR Can Be Used to Study GO:0090630 activation of GTPase activity
Knockout
CRISPR knockout of GTPase genes or their GEFs can abolish activation, revealing loss-of-function phenotypes. For example, Rac1 knockout impairs exercise-induced adaptations in skeletal muscle. Similarly, RGL2 knockout blocks Ral GTPase activation.
Point Mutation
Point mutations can be introduced to mimic or disrupt GTPase activation. For instance, KRAS G12D mutation locks the GTPase in an active state, and CRISPR knock-in of this mutation is used to model cancer. Similarly, mutations in the switch regions can affect GEF binding.
Knock-in
Knock-in of tagged GTPases (e.g., GFP-Rac1) allows visualization and purification of active GTPases. This approach is useful for studying spatiotemporal activation. Additionally, knock-in of disease-associated mutations can model human disorders.
Overexpression
Overexpression of wild-type or constitutively active GTPases can enhance activation and downstream signaling. For example, overexpression of LDHA increases Rac1 activation in cancer cells. Overexpression of Ran promotes androgen receptor nuclear translocation.
How EDITGENE Supports activation of GTPase activity Research
Researchers studying activation of GTPase activity-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease phenotype. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such functional studies.
Contact EDITGENE today to design your custom CRISPR model for activation of GTPase activity research.
Frequently Asked Questions About activation of GTPase activity
What is GO:0090630 activation of GTPase activity?
GO:0090630 is a Gene Ontology biological process term defined as any process that initiates the activity of an inactive GTPase through the replacement of GDP by GTP.
What genes are involved in activation of GTPase activity?
Key genes include RAC1, KRAS, RAN, RAP1, RALA, RALB, and their regulators such as LDHA, RGL2, and B-type Plexins.
How is GTPase activation regulated?
GTPase activation is regulated by guanine nucleotide exchange factors (GEFs) that promote GDP-to-GTP exchange and GTPase-activating proteins (GAPs) that stimulate GTP hydrolysis.
What diseases are associated with dysregulated GTPase activation?
Dysregulated GTPase activation is linked to cancer, metabolic disorders, and neurological diseases.
What methods are used to study activation of GTPase activity?
Common methods include GTP loading assays, native mass spectrometry, FRET biosensors, CRISPR screens, and proteomics.
How can CRISPR be used to study GTPase activation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of GTPase genes to study their activation and downstream effects.
What is the role of Rac1 in exercise adaptation?
Rac1 activation in skeletal muscle mediates exercise training adaptations towards muscle glycogen resynthesis and protein synthesis.
How does LDHA activate Rac1?
LDHA acts as a noncanonical guanine nucleotide exchange factor for Rac1, promoting its activation in cancer cells.
What is the role of Ran GTPase in prostate cancer?
B-type Plexins promote Ran GTPase activity, which affects androgen receptor nuclear translocation in prostate cancer.
Can GTPase activation be targeted therapeutically?
Yes, inhibitors targeting GEFs or GTPases, such as covalent inhibitors of Rgl2 RalGEF, are being developed for cancer therapy.
Conclusion
The activation of GTPase activity (GO:0090630) is a fundamental biological process that controls diverse cellular functions and is implicated in numerous diseases. Understanding the molecular mechanisms, key genes, and regulatory networks involved is essential for both basic research and therapeutic development. CRISPR-based models and advanced screening technologies provide powerful tools to dissect this process. EDITGENE offers comprehensive services to support researchers in studying GTPase activation, from gene editing to bioinformatics analysis.
References
- 1. Liu J et al.. 2022. Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer.. Nat Metab 4(12):1830-1846 PMID: 36536137
- 2. Moghadamchargari Z et al.. 2019. Intrinsic GTPase Activity of K-RAS Monitored by Native Mass Spectrometry.. Biochemistry 58(31):3396-3405 PMID: 31306575
- 3. Garg R et al.. 2023. B-type Plexins promote the GTPase activity of Ran to affect androgen receptor nuclear translocation in prostate cancer.. Cancer Gene Ther 30(11):1513-1523 PMID: 37563360
- 4. M'Rabet L et al.. 1998. Activation of the small GTPase rap1 in human neutrophils.. Blood 92(6):2133-40 PMID: 9731072
- 5. Bum-Erdene K et al.. 2022. Covalent Fragment Screening Identifies Rgl2 RalGEF Cysteine for Targeted Covalent Inhibition of Ral GTPase Activation.. ChemMedChem 17(6):e202100750 PMID: 35061330
- 6. Jiang H et al.. 1995. Involvement of Ral GTPase in v-Src-induced phospholipase D activation.. Nature 378(6555):409-12 PMID: 7477381
- 7. Raun SH et al.. 2025. Skeletal muscle Rac1 mediates exercise training adaptations towards muscle glycogen resynthesis and protein synthesis.. Redox Biol 86:103844 PMID: 40886619
- 8. Treisman GJ et al.. 1985. Inhibition of a low Km GTPase activity in rat striatum by calmodulin.. J Neurochem 44(2):518-25 PMID: 2981286
